Showing posts with label raffles medical. Show all posts
Showing posts with label raffles medical. Show all posts

26 April 2018

3 Stocks To Look At Now

This week, USD has been on a rise. And the weekly chart of STI looks to set for a correction to 3520 for this week before any chance that the rally may continue. At the same time, FOMC meeting is on 1 May. So probably market should be relatively quiet for now.

Safe haven assets such as gold seem to have bottomed and could possibly rise again if the equities markets were to correct further.

Straits Times index






Personal list of stocks to look at:




Parkson

Parkson Retail O9E : totally oversold, a bottom has formed at 0.050.

Retail business has been turning around and changing business model Currently, the share lacks market focus. Yet this is a chance to buy when the prices are low for a good bargain.

 No doubt volume is very low, it is good for to buy and hold to wait for the upcoming results on 1st May. The coming quarter results should include the CNY as well as Hari Raya festival sales, which (hopefully) it is good and improving.





Keppel corp 0.14 dividends XD 25/04/18

possible after XD tomorrow price may fall back to 8.10 and hover around the 8.00 mark as before.
So the question is to decide the collect the dividends by holding on, or to sell it for profits by today.




Raffles Medical

A defensive stock that looks to break 1.20. The Chong Qing hospital will be opening in 2H18. which this is an excellent news that should give some positive boost to the price.
Not to mention there is 1% div per annum. It is not a lot, but its dividends have been stable and consistent since 2000.




at
Labels: , ,

24 June 2016

UK voted to LEAVE EU

Given that UK has voted to leave EU, this is a major change in the market environment.  As such, expect some volatility in the market.


Please watch for the bluechip shares such as :

  • Comfort Delgro
  • DBS
  • UOL
  • Ascott Reits
  • Raffles Medical (trade within the range 1.50 to 1.58)
  • SPH


Also you may want to avoid Singpost, Sembcorp, Keppel and Genting

my 2 cents.
at
Labels: , , , , ,

22 February 2016

Raffles Med: FY15 Results Flash: In line. Look Forward To Better Momentum Ahead




Raffles Medical (RFMD SP)        BUY (Maintained)


FY 15 results:  Results in line. Look forward to better momentum ahead

Analyst: Andrew Chow Tel: (65) 6590 6633
Company
Share price(S$)
Recommendation
Our Target Price(S$)
Within Expectation (Y/N)
EPS FY15 (sen)
FY15 EPS yoy (%)
Highlights of Results
Raffles Med 4.17 Buy 5.05 In line 12.15 1% See attached comments

   
RFMD SP FY15



  • Earnings within expectations. No surprises as its FY15 net profit of S$69.3m (+2.4% yoy) was within our (S$68.9m) and market expectations. A final DPS was of 4.5 cents/share was announced, bringing the total DPS for FY15 to 6.0 cents, which is 9.1% higher than FY14's total DPS of 5.5 cents.
  • Slip in operating margin on higher staff. Operating margins slipped 1.8ppt to 19.6%, primarily due to a 12% yoy rise in staff costs, that outpaced revenue growth of 9.6% yoy. This is attributable to new hirings ahead of new expanded operations for its existing hospital and Raffles Medical Orchard. Looking ahead, we think staff costs will remain elevated ahead of the new wing expansion at its flagship hospital. The higher staff costs were also due to newly acquired subsidiaries in FY15. Other key costs such as inventory and contractedf services were well contained.
  • Solid cash balance. As at Dec 2016, its net cash balance is S$53.8m (S$0.09/share). Operating cashflows remain strong at S$73m in FY15.
  • Capacity for growth; BUY. We maintain BUY with a DCF based target price of S$5.05. Our forecasts is pending an analyst briefing this morning. We forecast FY16F EPS growth to pick up momentum as newly completed medical centres (Raffles Medical Orchard and its new facility at Holland V) and clinics contribute. Also, we see a moderate recovery in volume of foreign patients to underpin growth in its hospitals admission.


This transmission has been issued by a member of the UOB Kay Hian Group for the information of the addressee only and should not be reproduced and/or distributed to any other person. Each page attached hereto must be read in conjunction with any disclaimer which forms part of it. Unless otherwise stated, this transmission is neither an offer nor the solicitation of an offer to sell or purchase any investment. Its comments are based on information obtained from sources believed to be reliable but UOB Kay Hian Group makes no representations and accepts no responsibility or liability as to its completeness or accuracy.
at
Labels:
Subscribe to: Posts (Atom)
//amazon